MINtS Real-World Analysis: Annual Trends in Gene Mutation Detection Rates by Sample Type, Sample Collection Method, and Extracted Nucleic Acid Quantity Using the MINtS Multi-Gene Mutation Test

MINtS Real-World Analysis: Annual Trends in Gene Mutation Detection Rates by Sample Type, Sample Collection Method, and Extracted Nucleic Acid Quantity Using the MINtS Multi-Gene Mutation Test - MINtS Real-World Analysis

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000056869

Enrollment

10000

Registered

2025-02-10

Start date

2024-12-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who consent to the collection, analysis, and presentation of data on pathological type, specimen type, extracted nucleic acid amount, specimen collection technique, and genetic mutation test results, under the condition that their personal information remains undisclosed, while MINtS is performed in the context of insurance-covered medical care

Exclusion criteria

Exclusion criteria: Patients who do not fulfill the inclusion criteria

Design outcomes

Primary

Measure	Time frame
Gene mutation detection rates by histological type, sample type, and extracted nucleic acid quantity	—

Secondary

Measure	Time frame
Nucleic acid quantity and gene mutation detection rates by collection technique, the estimated proportion of carcinogenic driver mutations in lung cancer in Japan based on the primary endpoint, and the temporal changes in the primary endpoint	—

Countries

Japan

Contacts

Public ContactMasanori Kawakami

The University of Tokyo Hospital Respiratory Medicine

kawakamim-int@h.u-tokyo.ac.jp0338155411

Outcome results